259 related articles for article (PubMed ID: 9436954)
21. [Daily single-dose aminoglycoside administration. Therapeutic and economic benefits].
Knudsen LM; Frimodt-Møller N; Hansen MT; Hippe E
Ugeskr Laeger; 1993 May; 155(19):1436-41. PubMed ID: 8316969
[TBL] [Abstract][Full Text] [Related]
22. Overview of the efficacy of isepamicin in the adult core clinical trial programme.
Carbon C
J Chemother; 1995 Jun; 7 Suppl 2():79-85. PubMed ID: 8622115
[TBL] [Abstract][Full Text] [Related]
23. Cephalosporin therapeutics for intensive care infections.
Salacata A; Chow JW
New Horiz; 1993 May; 1(2):181-6. PubMed ID: 7922401
[TBL] [Abstract][Full Text] [Related]
24. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
Ko WC; Lee HC; Chuang YC; Liu CC; Wu JJ
J Infect; 2000 May; 40(3):267-73. PubMed ID: 10908022
[TBL] [Abstract][Full Text] [Related]
25. Aminoglycoside combinations versus beta-lactams alone for penetrating abdominal trauma: a meta-analysis.
Hooker KD; DiPiro JT; Wynn JJ
J Trauma; 1991 Aug; 31(8):1155-60. PubMed ID: 1831511
[TBL] [Abstract][Full Text] [Related]
26. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.
Sobieszczyk ME; Furuya EY; Hay CM; Pancholi P; Della-Latta P; Hammer SM; Kubin CJ
J Antimicrob Chemother; 2004 Aug; 54(2):566-9. PubMed ID: 15269195
[TBL] [Abstract][Full Text] [Related]
28. The use of aminoglycosides in neutropenic patients.
Cometta A; Glauser MP
Schweiz Med Wochenschr Suppl; 1996; 76():21S-27S. PubMed ID: 8677415
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis: randomized controlled trials of clindamycin/aminoglycoside vs. beta-lactam monotherapy for the treatment of intra-abdominal infections.
Falagas ME; Matthaiou DK; Karveli EA; Peppas G
Aliment Pharmacol Ther; 2007 Mar; 25(5):537-56. PubMed ID: 17305755
[TBL] [Abstract][Full Text] [Related]
30. Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis.
Michalsen H; Bergan T
Scand J Infect Dis Suppl; 1981; 29():92-7. PubMed ID: 6947408
[TBL] [Abstract][Full Text] [Related]
31. Aminoglycoside adaptive resistance.
Karlowsky JA; Zelenitsky SA; Zhanel GG
Pharmacotherapy; 1997; 17(3):549-55. PubMed ID: 9165557
[TBL] [Abstract][Full Text] [Related]
32. Emerging resistance problems among respiratory tract pathogens.
Lister PD
Am J Manag Care; 2000 May; 6(8 Suppl):S409-18. PubMed ID: 10977480
[TBL] [Abstract][Full Text] [Related]
33. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
DeJace P; Klastersky J
Am J Med; 1986 Jun; 80(6B):29-38. PubMed ID: 3524218
[TBL] [Abstract][Full Text] [Related]
34. Single-agent versus combination antibiotic therapy in the management of intraabdominal infections.
DiPiro JT; Cué JI
Pharmacotherapy; 1994; 14(3):266-72. PubMed ID: 7937268
[TBL] [Abstract][Full Text] [Related]
35. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():17-32. PubMed ID: 15953020
[TBL] [Abstract][Full Text] [Related]
36. The role of aminoglycosides in modern therapy.
Beaucaire G
J Chemother; 1995 Jun; 7 Suppl 2():111-23. PubMed ID: 8622100
[TBL] [Abstract][Full Text] [Related]
37. Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
Akova M
Int J Clin Pract Suppl; 2002 Mar; (125):19-27; discussion 37-9. PubMed ID: 12014853
[TBL] [Abstract][Full Text] [Related]
38. Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapy.
Barriere SL
Pharmacotherapy; 1992; 12(5):397-402. PubMed ID: 1437700
[TBL] [Abstract][Full Text] [Related]
39. The aminoglycosides.
Edson RS; Terrell CL
Mayo Clin Proc; 1999 May; 74(5):519-28. PubMed ID: 10319086
[TBL] [Abstract][Full Text] [Related]
40. Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
Lode H
Int J Clin Pract Suppl; 2002 Mar; (125):10-17; discussion 37-9. PubMed ID: 12014852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
